Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report
The regulatory landscape for cannabidiol (CBD) in the European Union has entered a new era. As of early 2025, the European Food Safety Authority (EFSA) has enacted its most demanding update yet to the Novel Food guidance—casting significant uncertainty over the future of CBD products in Europe. EFSA’s 2025 requirements call for substantially more human safety data, deeper toxicological insights, and meticulous manufacturing transparency in all dossiers. For brands and suppliers seeking EU authorization under the keywords "EFSA CBD novel food 2025 EU authorization," these changes mean the process now starts from a higher bar.
The European Commission’s Novel Food Catalogue (updated as of 2025) continues to classify “CBD extract” as a novel food. No product containing CBD extract (regardless of source) has yet been authorized for the EU market. Thousands of applications are either paused or require extensive supplementation, particularly focused on safety and toxicology.
EFSA’s latest update (see official EFSA guidance summary) brings sharply increased expectations in:
While EFSA delivers scientific opinions, enforcement and market permissions remain largely a matter for national authorities. This results in a "patchwork" across the EU:
For brands, this means legal availability and risk of enforcement can vary dramatically depending on the target market. Cross-border e-commerce carries heightened risk of seizure, customs recalls, or fines if national rules are breached.
With stricter scientific review and potential for market disruption, how should brands navigate the EFSA’s new terrain?
Key Takeaway: In 2025, the EU CBD food market is, effectively, back to square one. Actor agility, scientific rigor, and deep compliance planning have never been more critical.
For brands and investors in the European CBD space, close attention to evolving EFSA demands, national enforcement trends, and ongoing compliance best practice is non-negotiable. For ongoing updates, dossier support, and operational guidance tailored to EFSA CBD novel food 2025 EU authorization, rely on CannabisRegulations.ai.
Empower your business with confidence—stay informed, stay compliant!